Published: Aug 09, 2022
Updated: Feb 26, 2026

Blood cancer is a malignant condition in which the blood cells lose their ability to function normally and grow out of control, hindering the function of normal blood cells. Blood cancer typically starts in the cells that procedure different types of blood cells, also known as the bone marrow. The different types of blood cells include red blood cells, white blood cells, and platelets. The cancer may also form in the cells produced by the marrow, such as lymphocytes or plasma cells (type of white blood cells). The normal blood production by the bone marrow is put to a halt as a result of the growth of abnormal types of (malignant) cells in the blood-forming tissue.
Blood cancer can be differentiated into three main categories or types:
1. LeukemiasLeukemia is a type of blood cancer that starts in the bone marrow and blood. It is the most common type of blood cancer that is characterized by excessive production of white blood cells that do not function properly or inadequate production of platelets and/or red blood cells.There are different types of leukemia, differentiated based on how aggressive it is and what type of cells are involved. Some of the most common types include the following:
Acute/chronic leukemia: Acute leukemia is characterized by blasts, which are immature blood cells. It needs to be treated immediately because of its aggressive nature. The blast cells can proliferate quickly and indicate defective function. On the other hand, more developed cells that can temporarily function normally are involved in chronic leukemia. In this case, the condition can go undiagnosed for a few years. They develop and divide slowly and symptoms may not appear for a while.
Lymphocytic leukemia: This type of leukemia affects the lymphocytes, which form a part of the lymphatic tissue, which is in turn responsible for immunity. Myelogenous leukemia: This type of leukemia affects the myeloid cells, which are responsible for the production of red blood cells, white blood cells, and platelets.Some of the most common forms of leukemias based on the categories defined above include the following:
2. LymphomasOne kind of blood cancer that affects the lymphatic system is called lymphoma. The lymphatic system is responsible for both the body's removal of extra fluid and the synthesis of immune cells. The white blood cells called lymphocytes, which are in charge of defending against infections caused by pathogens, are the main objective of this particular type of cancer. The malignant lymphocytes eventually develop into lymphoma, which grows aggressively in the lymph nodes and other tissues in the body. Further, there are two main types of lymphomas:
Non-Hodgkin's Lymphoma: It is a type of lymphoma that develops in lymphocytes.
Hodgkin's Lymphoma: This type of cancer also develops in the lymphocytes but is characterized by a particular type of abnormal lymphocyte called the Reed-Sternberg cell.
3. Multiple MyelomaMyelomas, also known as multiple myeloma, is a cancer that affects the plasma cells, which are responsible for forming disease-fighting antibodies in humans. These are a type of white blood cell. Myeloma is also known as multiple myeloma since the malignant plasma cells are often present at multiple locations.Because multiple myeloma affects the formation of plasma cells, the person's immune system is severely compromised, making them more vulnerable to infections.Depending on the kind of heavy and/or light chain antibodies that the afflicted plasma cells produce, myeloma can be further classified into different types.
Irrespective of the type of blood cancer, some of the common symptoms include the following:
All types of blood cancers, even those that are inherited, are a result of genetic mutation in the normal DNA in the blood cells. These mutations may result because of a variety of reasons, including the following:
Several diagnostic tests are required to be done before a firm diagnosis can be established and the treatment protocol for the patient can be decided. Some of the tests that are required to be completed before the diagnosis of the patient can be concluded include the following:
There may be some additional tests that may be required based on the clinical status and past medical history. These tests may or may not be directly linked to blood cancer. A biopsy is necessary for cancer staging, which is a crucial factor in determining the kind and stage of the disease. This is often accomplished by taking measurements of the tumor's size and location and comparing results with those of previous studies. Since blood cancer is different from solid tumors, it uses a different staging system. This particular technique involves the volume of blood present, swelling of the liver or spleen, size and quantity of abnormal malignant cells, genetic abnormalities, and degree of bone damage. The outcome of this assessment is then correlated with the information retrieved from the radiological scans. Apart from staging, grading of the blood cancer is performed in the case of lymphomas. Grading helps identify whether the cancer is high-grade, intermediate-grade, or low-grade.
| Type of Treatment | Minimum Cost | Maximum Cost |
| Diagnostics | $1,000 | $5,000 |
| Cost of Chemotherapy | $600 | $700 |
| Cost of Immunotherapy | $3000 | $5000 |
| Cost of Targeted Therapy | $8000 | 12000 |
| Cost of Bone Marrow Transplant | $25,000 | $35,000 |
| Cost of Radiation Therapy | $4000 | $5,000 |
The cost of treating blood cancer is influenced by several factors, including the type of treatment, how long it takes, and many other intricate details. Some of the most common factors affecting the cost of blood cancer treatment include the following:
Some of the other factors such as patient location and demographics and geographical availability of the treatment also matter in terms of the overall cost of treatment that a patient is likely to pay.
There are many parameters that are taken into consideration before planning for the treatment of patients. Some of the factors that are taken into consideration before subjecting the patient to any type of treatment for blood cancer include the following:
Blood cancer treatment in India is available at several multi-super specialty hospitals. Many patients from countries around the world travel to India for treatment of blood cancer in India because almost all new techniques and approaches used for treatment are available.The following are some of the most common forms of blood cancer treatment available in India:
| Artemis Hospital, Gurugram | Fortis Hospital, Noida | Max Super Specialty Hospital, Saket |
| Nanavati Max Hospital, Mumbai | Medanta â The Medicity, Gurugram | Pushpawati Singhania Research Institute in New Delhi, |
| Dr. Pawan Kumar Singh | Dr. Ashok Vaid | Dr. Divya Bansal |
| Dr. Vinod Raina | Dr. Mitu Papneja Shrikhande | Dr. Gaurav Dixit |

With over 18 years of distinguished clinical experience, Dr. Vijita Jayan is a highly accomplished Clinical Director and Rehabilitation Specialist, renowned for her expertise in neuro-rehabilitation, functional recovery, and mobility-dependent case management. Her extensive practical knowledge enables her to design and implement individualized, evidence-based rehabilitation protocols that consistently yield measurable patient outcomes. A prolific researcher and academic writer, she has authored numerous peer-reviewed articles and research papers, significantly advancing the field of rehabilitative medicine. The recipient of multiple prestigious accolades, Dr. Jayan is widely regarded as one of the foremost authorities in Physical Medicine and Rehabilitation, continually shaping neuro-rehabilitative care through research, innovation, and clinical excellence.

Dr. Vishwas Kaushik, an accomplished Belgorod State University graduate with an MBBS, is known for his impactful contributions to healthcare. Driven by a passion for global well-being, he seamlessly led domestic operations at VMV Group of Companies and orchestrated success at Clear Medi Cancer Centre. His adept team management and operational skills have positioned him as a luminary in healthcare tourism, shaping a future where compassionate, world-class medical care knows no boundaries.





Delhi, India

Istanbul, Turkey

Istanbul, Turkey

Istanbul, Turkey